Yumioka T, Honda M, Shimizu R, Teraoka S, et al. Response to Platinum-based Chemotherapy Rechallenge for Patients With Pembrolizumab-refractory Urothelial Carcinoma. Anticancer Res 2021;41:5767-5773.
PMID: 34732450